Harmony Biosciences Holdings (HRMY) Interest Expenses (2023 - 2026)

Harmony Biosciences Holdings has disclosed Interest Expenses across 4 years of filings, most recently posting $3.2 million for Q1 2026.

• Interest Expenses for Q1 2026 came in at $3.2 million, down 15.69% year-over-year; the trailing twelve-month figure through Mar 2026 was $14.0 million (down 16.37% YoY), and the FY2025 annual result was $14.6 million, down 16.27% from the prior year.
• Interest Expenses came in at $3.2 million for Q1 2026 at Harmony Biosciences Holdings, down from $3.5 million in the prior quarter.
• In the past five years, Interest Expenses ranged from a high of $7.0 million in Q3 2023 to a low of $3.2 million in Q1 2026.
• The 4-year median for Interest Expenses is $4.3 million (2024), against an average of $4.5 million.
• Peak annual rise in Interest Expenses reached 12.24% in 2024, while the deepest fall reached 37.99% in 2024.
• Harmony Biosciences Holdings' Interest Expenses stood at $4.8 million in 2023, then retreated by 12.24% to $4.2 million in 2024, then slipped by 15.75% to $3.5 million in 2025, then slipped by 8.8% to $3.2 million in 2026.
• The last three Interest Expenses figures came in at $3.2 million (Q1 2026), $3.5 million (Q4 2025), and $3.6 million (Q3 2025), per Business Quant data.